Inventor · disambiguated record
Diane K. Luci
Also filed as: LUCI DIANE · LUCI DIANE K · LUCI DIANE KAREN
16 granted patents·3 pending applications·25 citations·filing 2004–2024
89Inventor score
Files withEASTERN VIRGINIA MEDICAL SCHOOL3MARYANOFF BRUCE E3UNIV CHICAGO3ARNER ELIAS SET JENOE2JANSSEN PHARMACEUTICA NV2
Top patents by PatentIndex Score
19 records- 0185US10899710B2Pyridines and their use in the treatment of cancerUS HEALTH·Filed 2016·Granted Jan 26, 2021·4 cites·20 claims
- 0284US10266488B24-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenaseEASTERN VIRGINIA MEDICAL SCHOOL·Filed 2014·Granted Apr 23, 2019·3 cites·9 claims
- 0381US11274077B24-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenaseEASTERN VIRGINIA MEDICAL SCHOOL·Filed 2020·Granted Mar 15, 2022·1 cites·20 claims
- 0480US8193191B2Urotensin II receptor antagonistsMARYANOFF BRUCE E·Filed 2011·Granted Jun 5, 2012·5 cites·26 claims
- 0579US9802904B2Inhibitors of the USP1/UAF1 deubiquitinase complex and uses thereofUS HEALTH·Filed 2013·Granted Oct 31, 2017·4 cites·4 claims
- 0678US8008299B2Urotensin II receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2008·Granted Aug 30, 2011·3 cites·19 claims
- 0777US10752581B24-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenaseEASTERN VIRGINIA MEDICAL SCHOOL·Filed 2019·Granted Aug 25, 2020·1 cites·13 claims
- 0874US7915260B2Urotensin II receptor antagonistsMARYANOFF BRUCE E·Filed 2007·Granted Mar 29, 2011·3 cites·28 claims
- 0970US2024415851A1Remodilins to prevent or treat cancer metastasis, glaucoma, and hypoxiaUNIV CHICAGO·Filed 2024·Application pending·0 cites
- 1062US7351711B2Tricyclic indanyls as integrin inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Apr 1, 2008·1 cites·29 claims
- 1156US12281060B2Remodilins for airway remodeling and organ fibrosisUNIV CHICAGO·Filed 2020·Granted Apr 22, 2025·0 cites·3 claims
- 1254US2022040207A1Remodilins to prevent or treat cancer metastasis, glaucoma, and hypoxiaUNIV CHICAGO·Filed 2020·Application pending·0 cites
- 1353US2024002350A1Protein and lipid therapeutic targetsUNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION·Filed 2021·Application pending·0 cites
- 1452US8536174B2Urotensin II receptor antagonistsMARYANOFF BRUCE E·Filed 2012·Granted Sep 17, 2013·0 cites·23 claims
- 1551US9079896B2Urotensin II receptor antagonistsKINNEY WILLIAM A·Filed 2009·Granted Jul 14, 2015·0 cites·6 claims
- 1645US8445514B2Urotensin II receptor antagonistsKINNEY WILLIAM A·Filed 2011·Granted May 21, 2013·0 cites·13 claims
- 1737US8759342B2Benzo[1,4]oxazin-3-one, benzo[1,4]thiazin-3-one and quinolin-2-one urotensin II receptor antagonistsSHYAMALI GHOSH·Filed 2007·Granted Jun 24, 2014·0 cites·32 claims
- 1834US10881653B2Tricyclic compounds and their use in the treatment of cancerARNER ELIAS SET JENOE·Filed 2016·Granted Jan 5, 2021·0 cites·18 claims
- 1928US11110089B2Pyridazinones and their use in the treatment of cancerARNER ELIAS SET JENOE·Filed 2016·Granted Sep 7, 2021·0 cites·15 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →